The Mef2 Transcription Network Is Disrupted in Myotonic Dystrophy Heart Tissue, Dramatically Altering miRNA and mRNA Expression
Cardiac dysfunction is the second leading cause of death in myotonic dystrophy type 1 (DM1), primarily because of arrhythmias and cardiac conduction defects. A screen of more than 500 microRNAs (miRNAs) in a DM1 mouse model identified 54 miRNAs that were differentially expressed in heart. More than...
Main Authors: | Auinash Kalsotra, Ravi K. Singh, Priyatansh Gurha, Amanda J. Ward, Chad J. Creighton, Thomas A. Cooper |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124713007833 |
Similar Items
-
microRNA-mRNA Profile of Skeletal Muscle Differentiation and Relevance to Congenital Myotonic Dystrophy
by: Sarah U. Morton, et al.
Published: (2021-03-01) -
Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
by: Marzena Wojciechowska, et al.
Published: (2018-04-01) -
MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
by: Arturo López Castel, et al.
Published: (2019-11-01) -
Global Increase in Circular RNA Levels in Myotonic Dystrophy
by: Karol Czubak, et al.
Published: (2019-07-01) -
RNA-based gene therapies for myotonic dystrophy type 1
by: Langlois, Marc-André
Published: (2003)